Scaling up stem cells

BioProcess International

Volumn 10, Issue SUPPL. 5, 2012, Pages 62-64

  Egloff, Matthieu ^a   Castillo, Jose ^a  

^a ATMI LifeSciences ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DISSOLVED OXYGEN; POLYSTYRENE; SCAFFOLD PROTEIN;

ADHERENT CELL; AUTOINFLAMMATORY DISEASE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BIOREACTOR; CELL CULTURE; CELL FUNCTION; CELL STRUCTURE; CELL THERAPY; GOOD MANUFACTURING PRACTICE; HEART DISEASE; HEART MUSCLE INJURY; HUMAN; INTERNAL CONSISTENCY; LABORATORY; LAMINAR FLOW; PHASE 2 CLINICAL TRIAL (TOPIC); QUALITY CONTROL; REPRODUCIBILITY; SCALE UP; SHEAR STRESS; SHORT SURVEY; STEM CELL; STEM CELL NICHE;

EID: 84863539884     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Short Survey

References (4)

1. Placzek MR, et al. Stem Cell Bioprocessing: Fundamentals and Principles. J. R. Soc. Interface 6, 2009: 209-232.
2. Rowley JA. Developing Cell Therapy Biomanufacturing Processes. Stem Cell Eng. 106(11) 2010: S50-S55; www.aiche.org/uploadedFiles/SBE/Restricted/ SBEOnlyNew/111050.pdf.
3. Rowley JA, et al. Meeting Lot-Size Challenges of Manufacturing Adherent Cells for Therapy. BioProcess Int. 10(3) 2012: S16-S22.
4. ntegrity Xpansion. ATMI: Bloomington, MN, 2012: www.atmi.com/ lifesciences/products/bioreactors/xpansion.html.